HSBC Holdings’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-19,559
| Closed | -$7.46K | – | 2707 |
|
|
2024
Q2 | $7.46K | Sell |
19,559
-561
| -3% | -$214 | ﹤0.01% | 2522 |
|
|
2024
Q1 | $13.5K | Sell |
20,120
-36,844
| -65% | -$24.7K | ﹤0.01% | 2587 |
|
|
2023
Q4 | $32.6K | Buy |
56,964
+420
| +0.7% | +$241 | ﹤0.01% | 2191 |
|
|
2023
Q3 | $33.9K | Hold |
56,544
| – | – | ﹤0.01% | 2130 |
|
|
2023
Q2 | $73.2K | Hold |
56,544
| – | – | ﹤0.01% | 2031 |
|
|
2023
Q1 | $98.1K | Buy |
56,544
+4,247
| +8% | +$7.37K | ﹤0.01% | 2077 |
|
|
2022
Q4 | $159K | Hold |
52,297
| – | – | ﹤0.01% | 2344 |
|
|
2022
Q3 | $262K | Buy |
52,297
+7,059
| +16% | +$35.4K | ﹤0.01% | 2059 |
|
|
2022
Q2 | $187K | Buy |
45,238
+29,324
| +184% | +$121K | ﹤0.01% | 2481 |
|
|
2022
Q1 | $94K | Buy |
+15,914
| New | +$94K | ﹤0.01% | 2748 |
|
|
2021
Q4 | – | Sell |
-22,158
| Closed | -$202K | – | 2815 |
|
|
2021
Q3 | $202K | Buy |
+22,158
| New | +$202K | ﹤0.01% | 2321 |
|
|
2021
Q1 | – | Sell |
-11,036
| Closed | -$174K | – | 2571 |
|
|
2020
Q4 | $174K | Buy |
+11,036
| New | +$174K | ﹤0.01% | 2405 |
|
|
2020
Q3 | – | Sell |
-44,086
| Closed | -$395K | – | 2352 |
|
|
2020
Q2 | $395K | Buy |
44,086
+12,048
| +38% | +$108K | ﹤0.01% | 1634 |
|
|
2020
Q1 | $199K | Buy |
+32,038
| New | +$199K | ﹤0.01% | 1892 |
|
|
2019
Q2 | – | Sell |
-30,500
| Closed | -$291K | – | 2200 |
|
|
2019
Q1 | $291K | Sell |
30,500
-35,008
| -53% | -$334K | ﹤0.01% | 1835 |
|
|
2018
Q4 | $752K | Buy |
+65,508
| New | +$752K | ﹤0.01% | 1384 |
|
|
2017
Q1 | – | Sell |
-11,961
| Closed | -$36K | – | 2024 |
|
|
2016
Q4 | $36K | Buy |
+11,961
| New | +$36K | ﹤0.01% | 2227 |
|